Janus Henderson Enterprise Fund Q4 2025 Portfolio Review [Seeking Alpha]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Seeking Alpha
Revolution Medicines (RVMD), another contributor, is a clinical-stage precision oncology company developing advanced cancer therapies. Constellation's visionary founder and CEO is retiring due to health concerns, and uncertainty around this transition weighed on the stock price. Additionally, enterprise software companies more broadly have been pressured by concerns that AI could act as a competitive disrupter, lowering barriers to entry, enabling new competition, or upending existing business models. CoStar Group (CSGP), another detractor, provides real estate information and analytics to the residential and commercial property markets. Galeanu Mihai/iStock via Getty Images The following segment was excerpted from the Janus Henderson Enterprise Fund Q4 2025 Commentary. We were pleased to see many of our disciplined growth-oriented investments rewarded during the quarter. Relative contributors included J.B. Hunt Transport This article was written by Quick Insights
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Janus Henderson Enterprise Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- On biotech's biggest stage, renewed excitement gets a stress test [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines (NASDAQ:RVMD) was given a new $143.00 price target on by analysts at Mizuho.MarketBeat
- JPM 26: Day 1 – drug prices and policy changes drive the agenda [Yahoo! Finance]Yahoo! Finance
RVMD
Earnings
- 11/5/25 - Miss
RVMD
Sec Filings
- 1/9/26 - Form 4
- 1/9/26 - Form 4
- 1/7/26 - Form 144
- RVMD's page on the SEC website